{
    "id": "31e3d3a6-c592-499f-e063-6394a90a58d3",
    "code": {
        "code": "34391-3",
        "codeSystem": "2.16.840.1.113883.6.1",
        "displayName": "HUMAN PRESCRIPTION DRUG LABEL"
    },
    "organization": "New HeightsRx, LLC",
    "effectiveTime": "20250403",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "chebi_id": null,
            "drugbank_id": "DB14478"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "CLEMASTINE FUMARATE",
            "code": "19259EGQ3D",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3738"
        }
    ],
    "indications": [
        {
            "text": "usage clemasz \u2122 ( clemastine fumarate tablets usp ) 2.68 mg indicated relief symptoms associated allergic rhinitis sneezing, rhinorrhea, pruritus, lacrimation. clemasz \u2122 ( clemastine fumarate tablets usp ) 2.68 mg also indicated relief mild, uncomplicated allergic skin manifestations urticaria angioedema. noted clemastine fumarate indicated dermatologic 2.68 mg level only.",
            "doid_id": "http://purl.obolibrary.org/obo/DOID_4483",
            "orphanet_id": null
        }
    ],
    "contraindications": [
        {
            "text": "usage nursing mothers higher risk antihistamines infants generally newborns prematures particular, antihistamine therapy contraindicated nursing mothers. usage lower respiratory disease antihistamines used treat lower respiratory tract symptoms including asthma. antihistamines also contraindicated following conditions: hypersensitivity clemastine fumarate antihistamines similar chemical structure. monoamine oxidase inhibitor therapy ( section ) .",
            "doid_id": "http://purl.obolibrary.org/obo/DOID_4",
            "orphanet_id": null
        }
    ],
    "warningsAndPrecautions": "antihistamines used considerable caution patients with: narrow angle glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction, symptomatic prostatic hypertrophy, bladder neck obstruction. usage children safety efficacy clemastine fumarate established children age 12 years. usage pregnancy experience pregnant women inadequate determine whether exists potential harm developing fetus. usage cns depressants clemastine additive effects alcohol cns depressants ( hypnotics, sedatives, tranquilizers, etc. ) . usage activities requiring mental alertness patients warned engaging activities requiring mental alertness driving car operating appliances, machinery, etc. usage elderly ( approximately 60 years older ) antihistamines likely cause dizziness, sedation, hypotension elderly patients.precautions clemastine fumarate used caution patients with: history bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease, hypotension. mao inhibitors prolong intensify anticholinergic ( drying ) effects antihistamines.",
    "adverseReactions": "transient drowsiness, common reaction associated clemastine fumarate, occurs relatively frequently may require discontinuation therapy instances. antihistaminic compounds noted following occurred one antihistamines and, therefore, kept mind prescribing drugs belonging class, including clemastine. frequent italicized. general: urticaria, rash, anaphylactic shock, photosensitivity, excessive perspiration, chills, dryness mouth, nose, throat. cardiovascular system: hypotension, headache, palpitations, tachycardia, extrasystoles. hematologic system: hemolytic anemia, thrombocytopenia, agranulocytosis. nervous system: sedation, sleepiness, dizziness, disturbed coordination , fatigue, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, euphoria, paresthesias, blurred vision, diplopia, vertigo, tinnitus, acute labyrinthitis, hysteria, neuritis, convulsions. gi system: epigastric distress, anorexia, nausea, vomiting, diarrhea, constipation. gu system: urinary frequency, difficult urination, urinary retention, early menses. respiratory system: thickening bronchial secretions, tightness chest wheezing, nasal stuffiness.",
    "indications_original": "INDICATIONS AND USAGE CLEMASZ \u2122 (Clemastine Fumarate Tablets USP) 2.68 mg are indicated for the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus, and lacrimation. CLEMASZ \u2122 (Clemastine Fumarate Tablets USP) 2.68 mg are also indicated for the relief of mild, uncomplicated allergic skin manifestations of urticaria and angioedema. It should be noted that clemastine fumarate is indicated for the dermatologic indications at the 2.68 mg dosage level only.",
    "contraindications_original": "CONTRAINDICATIONS Usage in Nursing Mothers Because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. Usage in Lower Respiratory Disease Antihistamines should not be used to treat lower respiratory tract symptoms including asthma. Antihistamines are also contraindicated in the following conditions: Hypersensitivity to clemastine fumarate or other antihistamines of similar chemical structure. Monoamine oxidase inhibitor therapy (see Drug Interactions section).",
    "warningsAndPrecautions_original": "WARNINGS Antihistamines should be used with considerable caution in patients with: narrow angle glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction, symptomatic prostatic hypertrophy, and bladder neck obstruction. Usage in Children Safety and efficacy of clemastine fumarate have not been established in children under the age of 12 years. Usage in Pregnancy Experience with this drug in pregnant women is inadequate to determine whether there is exists a potential for harm to the developing fetus. Usage with CNS Depressants Clemastine has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc.). Usage in Activities Requiring Mental Alertness Patients should be warned about engaging in activities requiring mental alertness such as driving a car or operating appliances, machinery, etc. Usage in the Elderly (approximately 60 years or older) Antihistamines are more likely to cause dizziness, sedation, and hypotension in elderly patients.PRECAUTIONS Clemastine fumarate should be used with caution in patients with: history of bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease, and hypotension. Drug Interactions MAO inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines.",
    "adverseReactions_original": "ADVERSE REACTIONS Transient drowsiness, the most common adverse reaction associated with clemastine fumarate, occurs relatively frequently and may require discontinuation of therapy in some instances. Antihistaminic Compounds It should be noted that the following reactions have occurred with one or more antihistamines and, therefore, should be kept in mind when prescribing drugs belonging to this class, including clemastine. The most frequent adverse reactions are italicized. General: Urticaria, drug rash, anaphylactic shock, photosensitivity, excessive perspiration, chills, dryness of the mouth, nose, and throat. Cardiovascular System: Hypotension, headache, palpitations, tachycardia, extrasystoles. Hematologic System: Hemolytic anemia, thrombocytopenia, agranulocytosis. Nervous System: Sedation, sleepiness, dizziness, disturbed coordination , fatigue, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, euphoria, paresthesias, blurred vision, diplopia, vertigo, tinnitus, acute labyrinthitis, hysteria, neuritis, convulsions. GI System: Epigastric distress, anorexia, nausea, vomiting, diarrhea, constipation. GU System: Urinary frequency, difficult urination, urinary retention, early menses. Respiratory System: Thickening of bronchial secretions, tightness of chest and wheezing, nasal stuffiness.",
    "drug": [
        {
            "name": "CLEMASZ",
            "drugbank_id": "DB00283"
        }
    ]
}